​​"I'm over 60. Am I too late for HRT?"

If you’re over 60 and still experiencing hot flashes, sleep problems, mood changes, or a general sense that your body has shifted in ways you don’t fully recognize, these symptoms can persist for years after menopause. Many women deal with this, and it can feel isolating, but it is a recognized and treatable pattern. We know that these symptoms can persist for 10 or more years in women AFTER they officially enter menopause; that’s a lot of time spent suffering! The bright side is you’re definitely not “too late” to ask about hormone therapy. The key is that you are in a category where the conversation has to be more individualized, more risk-aware, and frankly, more grown-up. Despite what is shown on social media, there is no one ‘hook’ or answer that is right for everyone. The reality is that there is a huge gray zone when it comes to this issue, and that often doesn’t fit well on an Instagram reel or a Facebook post.

Here’s the core evidence-based idea: age and time since menopause matter. The North American Menopause Society (NAMS) states that for women who start hormone therapy under 60 or within 10 years of menopause, the benefit-risk balance is generally favorable for bothersome symptoms and bone protection. For women who start over 60, or more than 10 years from menopause, that balance becomes less favorable because absolute risks (heart disease, stroke, blood clots, dementia) rise with age.  

If you’re over 60 or past the 10-year threshold, that doesn’t mean “no.” It means “let’s do this thoughtfully.”

What HRT can still help with after 60

Pros

• Vasomotor symptoms (hot flashes and night sweats)
  If these symptoms are still disrupting your life, hormone therapy remains the most effective treatment we have.
• Sleep and overall quality of life
  For many women, better sleep follows once nighttime hot flashes improve, which can have a ripple effect on mood, energy, and daily functioning.
• Bone health
  Systemic estrogen helps slow bone loss and reduce fracture risk while you are taking it. That said, for many women in their 60s, it is not considered first-line treatment for osteoporosis, but it may still play a supportive role depending on the situation.
• Genitourinary symptoms
  Vaginal dryness, painful intercourse, and recurrent urinary tract infections often respond very well to local vaginal estrogen therapy. This form is low-dose and works primarily in the local tissues, which gives it a different safety profile from systemic hormone therapy.

The real potential downsides we have to respect

Cons

• Blood clots and stroke
  Risk increases with age, and it also varies depending on the type of hormone therapy used. Route matters here: transdermal estrogen (patches or gels) and lower doses may carry a lower clotting risk than oral estrogen in some women.
• Heart disease
  This is one of the most misunderstood areas. Hormone therapy is notprescribed to prevent cardiovascular disease. In the Women's Health Initiative, combined estrogen-progestin therapy was associated with an increased risk of coronary heart disease early in treatment, particularly among women who started therapy later in life.
• Dementia
  Some research suggests that starting systemic hormone therapy later in life, particularly well beyond menopause, may be associated with a higher risk of dementia. That concern is part of why timing is emphasized in current guidelines. At the same time, the research landscape is not completely uniform. Some studies have suggested potential cognitive protection, while others show the opposite. The reality is that brain health, like most aspects of medicine, cannot be explained by a single variable.

Special note for women and heart disease

Heart disease is the #1 killer of women, and the menopausal transition is often a time when cardiometabolic risk quietly accelerates. Blood pressure, cholesterol, visceral fat, and insulin resistance can all shift during this period.

Researchers have proposed what is called the “timing hypothesis,” which suggests that estrogen may have more favorable vascular effects when it is started closer to menopause, and less benefit — or potential harm — when initiated later. The ELITE Trial provides some biological support for this idea, showing slower progression of subclinical atherosclerosis when estrogen therapy was started earlier rather than later.

Guidance from the American Heart Association is consistent with this perspective: hormone therapy may be appropriate for symptom relief in selected women, but it should not be used as a strategy to prevent cardiovascular disease.

So… are you too late?

No, but you may be in what many clinicians think of as the gray zone, where the best approach typically involves:

• using the lowest effective dose
• choosing the safest formulation and route for your individual risk profile
• being clear about the symptoms or goals being treated
• reassessing periodically as your health evolves

That’s the framework that tends to produce the most thoughtful decisions.

And ultimately, that’s the more useful question to ask. Not “can I take hormone therapy after 60?” but rather:

What problem are we trying to solve, what risks do I personally carry, and what is the safest path to feeling better?

Those answers rarely come from a generalized chart; they come from a careful conversation with a physician (sometimes more than one) who understands your health history, your priorities, and your tolerance for risk.

Because when it comes to menopause care after 60, the goal is not to follow a rule.

It’s to make a decision that actually fits you.

‍